Strengthening health systems for access to gene therapy in rare genetic disorders.

Bhatia, Sonal; Le Cam, Yann; Carrion, Juan; Diamond, Lauren; Fennessy, Paul; Gassman, Safiyya; Gutzwiller, Felix; Kagan, Stephen; Pankevich, Diana; Young Maloney, Jennifer; Mahadev, Nitin; Schulz, Martin; Wong-Rieger, Durhane; Morgese, Paolo

Bhatia, Sonal; Le Cam, Yann; Carrion, Juan; Diamond, Lauren; Fennessy, Paul; Gassman, Safiyya; Gutzwiller, Felix; Kagan, Stephen; Pankevich, Diana; Young Maloney, Jennifer; Mahadev, Nitin; Schulz, Martin; Wong-Rieger, Durhane; Morgese, Paolo.

Afiliación

Bhatia S; Pfizer, Inc., New York, NY, USA.
Le Cam Y; EURORDIS, Paris, France.
Carrion J; Aliber, Totana, Spain.
Diamond L; Pfizer, Inc., New York, NY, USA.
Fennessy P; Paul Fennessy Advisory, Melbourne, VIC, Australia.
Gassman S; Pfizer, Inc., New York, NY, USA.
Gutzwiller F; University of Zurich, Zurich, Switzerland.
Kagan S; Pfizer, Inc., New York, NY, USA.
Pankevich D; Pfizer, Inc., New York, NY, USA.
Young Maloney J; Pfizer, Inc., New York, NY, USA.
Mahadev N; Pfizer, Inc., New York, NY, USA.
Schulz M; Pfizer, Inc., New York, NY, USA.
Wong-Rieger D; Canadian Organization for Rare Disorders, Toronto, ON, Canada.
Morgese P; Alliance for Regenerative Medicine, Brussels, Belgium.

Mol Ther Methods Clin Dev ; 32(2): 101220, 2024 Jun 13.

Article en En | MEDLINE | ID: mdl-38516694

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google